CCNB1 and prostate carcinoma: We found that CCNB1, TPX2, CENPF, TOP2A, MKI67, ECT2, TK1, RRM2, NUSAP1, CKS2 were overexpressed consistently in the 568 TCGA Prostate Cancer (PRAD) samples.